Literature DB >> 20397781

The Dysmorphic Concern Questionnaire: A screening measure for body dysmorphic disorder.

Serafino G Mancuso1, Natalie P Knoesen, David J Castle.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the use of the Dysmorphic Concerns Questionnaire (DCQ) as a screening measure for body dysmorphic disorder (BDD) and to derive DCQ cutoff scores to facilitate the screening procedure.
METHOD: The DCQ was completed by 244 undergraduates (mean = 20.80, SD = 3.10 years) and 57 BDD outpatients (mean = 29.60, SD = 9.44 years) in Melbourne, Australia. The undergraduate sample was screened for eating disorders using the Eating Attitudes Test-26, and for BDD using the Body Dysmorphic Disorder Questionnaire.
RESULTS: The BDD outpatients obtained significantly higher scores on the DCQ than the undergraduates. This difference remained statistically significant after controlling for the severity of depression and social anxiety symptoms. A DCQ cutoff score of 9 resulted in the correct classification of 96.4% of BDD patients and 90.6% of undergraduates.
CONCLUSIONS: The results supported the use of the DCQ as a brief, sensitive, and specific screening instrument for BDD.

Entities:  

Mesh:

Year:  2010        PMID: 20397781     DOI: 10.3109/00048671003596055

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  26 in total

1.  A comparison study of body dysmorphic disorder versus social phobia.

Authors:  Megan M Kelly; Kristy Dalrymple; Mark Zimmerman; Katharine A Phillips
Journal:  Psychiatry Res       Date:  2012-09-19       Impact factor: 3.222

Review 2.  Shame in the obsessive compulsive related disorders: a conceptual review.

Authors:  Hilary Weingarden; Keith D Renshaw
Journal:  J Affect Disord       Date:  2014-09-20       Impact factor: 4.839

3.  Obsessive-compulsive and related disorder symptoms in the perinatal period: prevalence and associations with postpartum functioning.

Authors:  Michelle L Miller; Anne I Roche; Elizabeth Lemon; Michael W O'Hara
Journal:  Arch Womens Ment Health       Date:  2022-05-26       Impact factor: 4.405

4.  An Evaluation of the Body Dysmorphic Disorder Symptom Scale as a Measure of Treatment Response and Remission in Psychotherapy and Medication Trials.

Authors:  Berta J Summers; Susanne S Hoeppner; Clare C Beatty; Mark A Blais; Jennifer L Greenberg; Katharine A Phillips; Sabine Wilhelm
Journal:  Behav Ther       Date:  2021-12-24

5.  The Body Dysmorphic Disorder Symptom Scale: Development and preliminary validation of a self-report scale of symptom specific dysfunction.

Authors:  Sabine Wilhelm; Jennifer L Greenberg; Elizabeth Rosenfield; Irina Kasarskis; Aaron J Blashill
Journal:  Body Image       Date:  2016-03-11

Review 6.  The body dysmorphic disorder patient: to perform rhinoplasty or not?

Authors:  Panagiotis Ziglinas; Dirk Jan Menger; Christos Georgalas
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-05       Impact factor: 2.503

7.  Tanning addiction and psychopathology: Further evaluation of anxiety disorders and substance abuse.

Authors:  Lisham Ashrafioun; Erin E Bonar
Journal:  J Am Acad Dermatol       Date:  2013-12-25       Impact factor: 11.527

8.  Is body dysmorphic disorder associated with abnormal bodily self-awareness? A study using the rubber hand illusion.

Authors:  Ryan A Kaplan; Peter G Enticott; Jakob Hohwy; David J Castle; Susan L Rossell
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

9.  Ethnic/racial and gender differences in body image disorders among a diverse sample of sexual minority U.S. adults.

Authors:  Manuel Gonzales; Aaron J Blashill
Journal:  Body Image       Date:  2020-11-07

10.  The association between body dysmorphic symptoms and suicidality among adolescents and young adults: a genetically informative study.

Authors:  Georgina Krebs; Lorena Fernández de la Cruz; Frühling V Rijsdijk; Daniel Rautio; Jesper Enander; Christian Rück; Paul Lichtenstein; Sebastian Lundström; Henrik Larsson; Thalia C Eley; David Mataix-Cols
Journal:  Psychol Med       Date:  2020-09-17       Impact factor: 10.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.